• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    80 Biggest Movers From Yesterday

    5/4/22 5:04:58 AM ET
    $AERC
    $ARRY
    $ATKR
    $ATNF
    Environmental Services
    Utilities
    Miscellaneous manufacturing industries
    Consumer Discretionary
    Get the next $AERC alert in real time by email

    Gainers

    • Blue Water Vaccines, Inc. (NASDAQ:BWV) shares jumped 93.1% to close at $6.45 on Tuesday on above-average volume.
    • XORTX Therapeutics Inc. (NASDAQ:XRTX) gained 59.1% to close at $1.83 after the company announced that dosing of human subjects has been initiated in the XRX-OXY-101 bridging pharmacokinetics study.
    • Ostin Technology Group Co., Ltd. (NASDAQ:OST) surged 57.3% to settle at $4.75 on Tuesday.
    • Titan Medical Inc. (NASDAQ:TMDI) gained 32.7% to close at $0.5750 after the company announced the receipt of a $2.6 million purchase order from Medtronic.
    • Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) jumped 31.6% to close at $3.50 on Tuesday after the company and its partner MicroSafe Group DMCC received EPA approval for Nanocyn as a hospital-grade disinfectant.
    • Belite Bio, Inc (NASDAQ:BLTE) gained 30.8% to close at $11.60. The FDA has granted Fast Track Designation to Belite Bio’s LBS-008 for Stargardt disease (STGD1).
    • Sesen Bio, Inc. (NASDAQ:SESN) surged 30% to settle at $0.5126 after the company announced that it has initiated a process to review strategic alternatives which may include the sale of the company, a merger, acquisition or other business combination, a strategic partnership with one or more parties, or the licensing, sale or divestiture of some of the company's proprietary technologies.
    • Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) jumped 28.2% to close at $0.7059 on above-average volume.
    • Nuvectis Pharma, Inc. (NASDAQ:NVCT) jumped 25.2% to settle at $11.66.
    • Eqonex Limited (NASDAQ:EQOS) gained 24.2% to close at $2.05.
    • Nisun International Enterprise Development Group Co., Ltd (NASDAQ:NISN) gained 22.4% to close at $0.8190.
    • Borr Drilling Limited (NYSE:BORR) jumped 20.6% to close at $4.62.
    • CPS Technologies Corporation (NASDAQ:CPSH) gained 20.4% to close at $4.36.
    • CPS Technologies tweeted 'CPS Technologies is excited to announce that we have received a $1.2M order from our partners at Kinetic Protection for additional HybridTech Armor® panels in support of an on-going program...'
    • Credit Acceptance Corporation (NASDAQ:CACC) jumped 20.2% to close at $621.88 after the company reported better-than-expected Q1 results.
    • AeroClean Technologies, Inc. (NASDAQ:AERC) gained 19.9% to close at $3.14.
    • Enovix Corporation (NASDAQ:ENVX) shares rose 19.6% to close at $10.68. Enovix announced initial smartwatch battery order from leading global consumer electronics company.
    • JAKKS Pacific, Inc. (NASDAQ:JAKK) climbed 19.5% to settle at $15.89 following upbeat Q1 results.
    • Digital Media Solutions, Inc. (NYSE:DMS) gained 19.5% to close at $2.82.
    • LogicBio Therapeutics, Inc. (NASDAQ:LOGC) rose 19.1% to settle at $0.5599.
    • TETRA Technologies, Inc. (NYSE:TTI) jumped 18.9% to close at $4.40. Tetra Technologies recently posted Q1 adjusted EPS of $0.06.
    • Biomea Fusion, Inc. (NASDAQ:BMEA) rose 18% to settle at $3.54.
    • BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) gained 17.9% to settle at $1.65.
    • Shoals Technologies Group, Inc. (NASDAQ:SHLS) rose 17.8% to close at $12.96.
    • The Chemours Company (NYSE:CC) jumped 17.6% to close at $38.91 after the company reported better-than-expected Q1 adjusted EPS and sales results and raised its FY22 adjusted EBITDA guidance.
    • Cabaletta Bio, Inc. (NASDAQ:CABA) gained 17.4% to close at $1.69.
    • InnovAge Holding Corp. (NASDAQ:INNV) gained 17.4% to settle at $5.46.
    • CVR Energy, Inc. (NYSE:CVI) climbed 17.1% to settle at $29.82 following Q1 results.
    • Scully Royalty Ltd. (NYSE:SRL) gained 16.7% to close at $10.06.
    • Profound Medical Corp. (NASDAQ:PROF) surged 16.7% to settle at $8.86.
    • Xilio Therapeutics, Inc. (NASDAQ:XLO) jumped 16.6% to close at $4.08.
    • Titan International, Inc. (NYSE:TWI) surged 16.4% to settle at $16.14 after the company reported better-than-expected Q1 EPS and sales results.
    • Performance Shipping Inc. (NASDAQ:PSHG) rose 15.9% to close at $2.70.
    • Werewolf Therapeutics, Inc. (NASDAQ:HOWL) jumped 15.8% to close at $5.04.
    • Evelo Biosciences, Inc. (NASDAQ:EVLO) surged 15.5% to settle at $2.83.
    • SoundHound AI, Inc. (NASDAQ:SOUN) shares gained 15.3% to close at $12.62 on Tuesday. The company recently completed a SPAC merger deal last week and began trading on Thursday.
    • FTC Solar, Inc. (NASDAQ:FTCI) rose 14.9% to close at $3.54.
    • Western Digital Corporation (NASDAQ:WDC) gained 14.5% to close at $61.72 after Elliott Investment Management sent a letter to the Board of Western Digital, calling for a full strategic review of the value that could be created by separating its flash unit.
    • Array Technologies, Inc. (NASDAQ:ARRY) gained 14.3% to close at $8.24.
    • JE Cleantech Holdings Limited (NASDAQ:JCSE) surged 13.2% to close at $4.97.
    • Atkore Inc. (NASDAQ:ATKR) gained 13% to close at $108.80 after the company reported better-than-expected Q2 EPS and sales results. The company also issued Q2 EPS guidance above analyst estimates.
    • Harmonic Inc. (NASDAQ:HLIT) rose 12.9% to settle at $9.71 after the company reported better-than-expected Q1 adjusted EPS and sales results and issued Q2 and FY22 sales guidance above analyst estimates.
    • Catalent, Inc. (NYSE:CTLT) gained 10.9% to close at $99.95 after the company reported better-than-expected Q3 EPS and sales results. The company also raised its FY22 guidance.
    • Sequans Communications S.A. (NYSE:SQNS) rose 10.9% to close at $2.75 following strong Q1 results.
    • Monolithic Power Systems, Inc. (NASDAQ:MPWR) gained 11.3% to close at $457.48 after the company reported better-than-expected Q1 EPS and sales results and issued Q2 sales guidance above analyst estimates.
    • BP p.l.c. (NYSE:BP) gained 8% to close at $31.18. BP’s profits more than doubled to $6.2 billion in Q1, helped by soaring oil and gas prices, despite posting a massive loss after offloading its nearly 20% stake in a Russian-controlled oil company Rosneft.
    • IPG Photonics Corporation (NASDAQ:IPGP) rose 7.7% to close at $106.82. IPG Photonics reported first-quarter FY22 revenue growth of 7% year-on-year to $369.98 million, beating the consensus of $334.79 million.
    • Medifast, Inc. (NYSE:MED) jumped 7.7% to close at $188.03 following upbeat Q1 results.

     

     

    Losers

    • Spero Therapeutics, Inc. (NASDAQ:SPRO) shares tumbled 63.7% to close at $1.85 on Tuesday. Spero Therapeutics will defer current commercialization activities for tebipenem HBr based on feedback from a recent Late Cycle Meeting (LCM) with the FDA.
    • Blackboxstocks Inc. (NASDAQ:BLBX) dipped 34.4% to close at $3.05. Blackboxstocks completed its platform integration with E*TRADE Inc.
    • Chegg, Inc. (NYSE:CHGG) shares fell 30.3% to close at $17.42 after the company reported Q1 earnings results and issued Q2 and FY22 sales guidance below analyst estimates. Piper Sandler downgraded Chegg from Overweight to Neutral and lowered the price target from $44 to $21.
    • Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) dipped 25.1% to close at $0.9140 after the company reported Q4 earnings results. Following earnings, Raymond James lowered its price target on the stock from $14 to $5.
    • Kymera Therapeutics, Inc. (NASDAQ:KYMR) fell 24% to close at $24.88 following downbeat quarterly results.
    • Semler Scientific, Inc. (NASDAQ:SMLR) fell 22.9% to close at $36.52 after the company reported Q1 EPS results were lower year-over-year and issued Q2 sales guidance below analyst estimates.
    • Nutex Health, Inc. (NASDAQ:NUTX) fell 22.9% to close at $7.70.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) fell 22.4% to close at $6.62 after climbing around 43% on Monday.
    • Missfresh Limited (NASDAQ:MF) dipped 21.8% to close at $0.3498 on above-average volume.
    • Borqs Technologies, Inc. (NASDAQ:BRQS) shares fell 21.2% to close at $0.21 after dipping around 22% on Monday.
    • 180 Life Sciences Corp. (NASDAQ:ATNF) dipped 20.8% to close at $1.33 on above-average volume.
    • EverQuote, Inc. (NASDAQ:EVER) fell 17.7% to close at $12.16 after the company reported Q1 earnings results and issued Q2 and FY22 sales guidance below analyst estimates.
    • Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) dipped 17.6% to close at $37.18 after the company reported worse-than-expected Q1 sales results.
    • Swvl Holdings Corp. (NASDAQ:SWVL) dropped 17.2% to close at $7.24.
    • Harsco Corporation (NYSE:HSC) fell 16.7% to close at $8.56 after the company posted Q1 results and lowered FY22 guidance.
    • Vaxxinity, Inc. (NASDAQ:VAXX) dropped 16.5% to settle at $5.71.
    • Glatfelter Corporation (NYSE:GLT) fell 15.4% to close at $9.40 following Q1 results.
    • Cyngn Inc. (NASDAQ:CYN) dropped 15.1% to settle at $3.93.
    • Rockwell Automation, Inc. (NYSE:ROK) dipped 14.5% to close at $213.74 after the company reported Q2 earnings results and cut FY22 adjusted EPS guidance below estimates.
    • Expedia Group, Inc. (NASDAQ:EXPE) fell 14% to close at $150.31 after the company reported Q1 financial results.
    • Charge Enterprises, Inc. (NASDAQ:CRGE) dipped 14% to settle at $5.61.
    • CURO Group Holdings Corp. (NYSE:CURO) fell 13.7% to close at $10.10 following Q1 results.
    • 2U, Inc. (NASDAQ:TWOU) fell 13.5% to settle at $9.06.
    • Veru Inc. (NASDAQ:VERU) dipped 13.5% to close at $8.88.
    • Varonis Systems, Inc. (NASDAQ:VRNS) fell 12.2% to close at $38.35 after the company reported Q1 earnings results and issued FY22 sales guidance below analyst estimates.
    • Hayward Holdings, Inc. (NYSE:HAYW) fell 11.7% to close at $14.91 after the company reported a secondary offering of 22.5m shares of common stock by selling stockholders.
    • CNO Financial Group, Inc. (NYSE:CNO) dropped 11% to settle at $21.47 after the company reported Q1 EPS results were lower year over year.
    • J&J Snack Foods Corp. (NASDAQ:JJSF) fell 9.7% to close at $132.60 after the company reported worse-than-expected Q2 sales.
    • Matterport, Inc. (NASDAQ:MTTR) dropped 8.3% to settle at $5.55. Wedbush downgraded Matterport from Outperform to Neutral and lowered the price target from $10 to $6.
    • Luokung Technology Corp. (NASDAQ:LKCO) shares fell 7.8% to close at $0.5302 after jumping 17% on Monday.
    • MediaAlpha, Inc. (NYSE:MAX) fell 7.1% to close at $14.05.
    • FMC Corporation (NYSE:FMC) dropped 6.3% to close at $123.50 after the company reported Q1 financial results.
    • Fabrinet (NYSE:FN) fell 5.8% to close at $93.63 following downbeat Q3 results.
    Get the next $AERC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AERC
    $ARRY
    $ATKR
    $ATNF

    CompanyDatePrice TargetRatingAnalyst
    Varonis Systems Inc.
    $VRNS
    2/5/2026$30.00Neutral → Buy
    DA Davidson
    Fabrinet
    $FN
    2/4/2026$540.00Peer Perform → Outperform
    Wolfe Research
    Western Digital Corporation
    $WDC
    1/30/2026$200.00 → $325.00Buy
    TD Cowen
    Kymera Therapeutics Inc.
    $KYMR
    1/28/2026$133.00Overweight
    Barclays
    Array Technologies Inc.
    $ARRY
    1/28/2026$11.00Outperform → Neutral
    Robert W. Baird
    Varonis Systems Inc.
    $VRNS
    1/26/2026$41.00Overweight → Equal-Weight
    Morgan Stanley
    Rockwell Automation Inc.
    $ROK
    1/20/2026Outperform → Perform
    Oppenheimer
    Monolithic Power Systems Inc.
    $MPWR
    1/15/2026Equal Weight → Overweight
    Wells Fargo
    More analyst ratings

    $AERC
    $ARRY
    $ATKR
    $ATNF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Varonis Systems upgraded by DA Davidson with a new price target

    DA Davidson upgraded Varonis Systems from Neutral to Buy and set a new price target of $30.00

    2/5/26 6:52:31 AM ET
    $VRNS
    Computer Software: Prepackaged Software
    Technology

    Fabrinet upgraded by Wolfe Research with a new price target

    Wolfe Research upgraded Fabrinet from Peer Perform to Outperform and set a new price target of $540.00

    2/4/26 8:55:11 AM ET
    $FN
    Telecommunications Equipment
    Utilities

    TD Cowen reiterated coverage on Western Digital with a new price target

    TD Cowen reiterated coverage of Western Digital with a rating of Buy and set a new price target of $325.00 from $200.00 previously

    1/30/26 6:45:51 AM ET
    $WDC
    Electronic Components
    Technology

    $AERC
    $ARRY
    $ATKR
    $ATNF
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ENTADFI issued to VERU INC

    Submission status for VERU INC's drug ENTADFI (ORIG-1) with active ingredient FINASTERIDE;TADALAFIL has changed to 'Approval' on 12/09/2021. Application Category: NDA, Application Number: 215423, Application Classification: Type 4 - New Combination

    12/13/21 8:12:46 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AERC
    $ARRY
    $ATKR
    $ATNF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Massengill Matthew E sold $9,616,466 worth of shares (36,926 units at $260.43) (SEC Form 4)

    4 - WESTERN DIGITAL CORP (0000106040) (Issuer)

    2/6/26 6:09:23 PM ET
    $WDC
    Electronic Components
    Technology

    Chief Legal Officer & Corp Sec Tregillis Cynthia L sold $1,833,922 worth of shares (6,780 units at $270.49), decreasing direct ownership by 5% to 136,538 units (SEC Form 4)

    4 - WESTERN DIGITAL CORP (0000106040) (Issuer)

    2/6/26 6:09:36 PM ET
    $WDC
    Electronic Components
    Technology

    Erdtmann Rainer M decreased direct ownership by 21% to 572,427 units (SEC Form 5)

    5 - Biomea Fusion, Inc. (0001840439) (Issuer)

    2/6/26 4:15:03 PM ET
    $BMEA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AERC
    $ARRY
    $ATKR
    $ATNF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Asher Daniel bought $62,974 worth of shares (12,300 units at $5.12) (SEC Form 4)

    4 - SEQUANS COMMUNICATIONS (0001383395) (Issuer)

    1/28/26 4:31:28 PM ET
    $SQNS
    Semiconductors
    Technology

    Large owner Asher Daniel bought $222,513 worth of shares (42,260 units at $5.27) (SEC Form 4)

    4 - SEQUANS COMMUNICATIONS (0001383395) (Issuer)

    1/22/26 5:09:00 PM ET
    $SQNS
    Semiconductors
    Technology

    Chief Medical Officer Chang David J. bought $19,888 worth of shares (8,800 units at $2.26) (SEC Form 4)

    4 - Cabaletta Bio, Inc. (0001759138) (Issuer)

    1/21/26 6:56:58 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AERC
    $ARRY
    $ATKR
    $ATNF
    SEC Filings

    View All

    SEC Form 144 filed by Monolithic Power Systems Inc.

    144 - MONOLITHIC POWER SYSTEMS INC (0001280452) (Subject)

    2/6/26 9:00:55 PM ET
    $MPWR
    Semiconductors
    Technology

    SEC Form 8-K filed by Werewolf Therapeutics Inc.

    8-K - Werewolf Therapeutics, Inc. (0001785530) (Filer)

    2/6/26 4:41:00 PM ET
    $HOWL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Biomea Fusion Inc.

    SCHEDULE 13G/A - Biomea Fusion, Inc. (0001840439) (Subject)

    2/6/26 4:30:02 PM ET
    $BMEA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AERC
    $ARRY
    $ATKR
    $ATNF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Shoals Technologies Group Secures Key Initial Win with the ITC to Protect U.S. Energy Innovation

    PORTLAND, Tenn., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. ("Shoals") (NASDAQ:SHLS), a global leader in electrical infrastructure solutions for the energy transition market, announced today that the U.S. International Trade Commission ("ITC") has issued a favorable initial determination in Shoals' patent infringement complaint against Voltage, LLC ("Voltage") and its related foreign entity. On February 6, 2026, an Administrative Law Judge (ALJ) at the ITC issued an initial finding that Voltage violated Section 337 of the Tariff Act of 1930 by importing LYNX trunk bus products into the United States. Shoals' patented Big Lead Assembly ("BLA") solution, invented, eng

    2/6/26 4:24:37 PM ET
    $SHLS
    Semiconductors
    Technology

    JAKKS Pacific, Inc. Announces Fourth Quarter and Full-Year 2025 Earnings Call

    SANTA MONICA, Calif., Feb. 06, 2026 (GLOBE NEWSWIRE) -- JAKKS Pacific, Inc. (NASDAQ:JAKK) will announce its fourth quarter and full-year 2025 financial results on Thursday, February 19, 2026 after the close of the stock market. The Company invites analysts, investors and media to listen to a teleconference scheduled for 5:00 p.m. ET / 2:00 p.m. PT on February 19, 2026 to discuss the results, and potentially future plans and prospects. A live webcast of the call will be available on the "Investor Relations" page of the Company's website at www.jakks.com/investors. To access the call by phone, please go to this link (4Q25 Registration link), and you will be provided with dial-in details. To

    2/6/26 9:00:00 AM ET
    $JAKK
    Recreational Games/Products/Toys
    Consumer Discretionary

    Hayward Holdings Announces Fourth Quarter and Full Year 2025 Earnings Release and Conference Call Date

    Hayward Holdings, Inc. (NYSE:HAYW) ("Hayward" or the "Company"), a global designer, manufacturer, and marketer of a broad portfolio of pool and outdoor living technology, announced today it will report its fourth quarter and full year 2025 earnings results on Wednesday, February 25, 2026. Following the earnings release, the Company will hold a conference call to discuss the results at 9:00 a.m. Eastern Time that day. Interested investors and other parties can listen to a webcast of the live conference call by logging onto the Investor Relations section of the Company's website at https://investor.hayward.com/events-and-presentations/default.aspx. An earnings presentation will be posted to

    2/6/26 8:00:00 AM ET
    $HAYW
    Industrial Machinery/Components
    Industrials

    $AERC
    $ARRY
    $ATKR
    $ATNF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by CVR Energy Inc.

    SC 13D/A - CVR ENERGY INC (0001376139) (Subject)

    1/7/25 6:12:47 AM ET
    $CVI
    Integrated oil Companies
    Energy

    Amendment: SEC Form SC 13D/A filed by Semler Scientific Inc.

    SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)

    12/12/24 4:16:00 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/6/24 4:05:57 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AERC
    $ARRY
    $ATKR
    $ATNF
    Leadership Updates

    Live Leadership Updates

    View All

    XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems

    CALGARY, Alberta, Feb. 04, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU)), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, announces that further to its press release of October 17, 2025 and an update on December 31, 2025, the Company has entered into an extension agreement with Vectus Biosystems Limited ("Vectus") to allow further time to complete the acquisition of the Renal Anti-Fibrotic Therapeutic Program from Vectus (the "Acquisition"). The term sheet entered into October 17th (the "Term Sheet") to acquire the novel new chemical

    2/4/26 6:00:00 PM ET
    $XRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FMC Corporation sets 2026 priorities and announces exploration of strategic options including but not limited to the sale of the company

    Company reports 2025 fourth quarter and full year results, provides 2026 outlook  The organization continues to focus on its 2026 operational priorities, including strengthening the balance sheet, improving the competitiveness of its core portfolio, managing its post-patent Rynaxypyr® active strategy and supporting growth of new active ingredientsThe FMC Board of Directors has authorized the exploration of strategic options, including but not limited to, the sale of the company to unlock shareholder value and ensure its growth and core portfolios are best positioned for long-term success PHILADELPHIA, Feb. 4, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) today announced its 2026 prioritie

    2/4/26 5:00:00 PM ET
    $FMC
    Major Chemicals
    Industrials

    Enovix Announces Leadership Transition to Support Manufacturing Scale-Up

    FREMONT, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Enovix Corporation (NASDAQ:ENVX) ("Enovix"), a global high-performance battery company, today announced a leadership transition in its operations organization, including the planned retirement of its Chief Operating Officer, as the company prepares to commence mass production. The transition reflects Enovix's focus on proven, high-volume battery manufacturing leadership as it moves toward sustained production for smartphone, smart eyewear, and defense applications. Enovix expressed its appreciation for Ajay Marathe's leadership and service, including his role in helping establish the company's manufacturing presence at Fab2 in Malaysia. Th

    1/20/26 8:30:00 AM ET
    $ENVX
    Industrial Machinery/Components
    Miscellaneous

    $AERC
    $ARRY
    $ATKR
    $ATNF
    Financials

    Live finance-specific insights

    View All

    JAKKS Pacific, Inc. Announces Fourth Quarter and Full-Year 2025 Earnings Call

    SANTA MONICA, Calif., Feb. 06, 2026 (GLOBE NEWSWIRE) -- JAKKS Pacific, Inc. (NASDAQ:JAKK) will announce its fourth quarter and full-year 2025 financial results on Thursday, February 19, 2026 after the close of the stock market. The Company invites analysts, investors and media to listen to a teleconference scheduled for 5:00 p.m. ET / 2:00 p.m. PT on February 19, 2026 to discuss the results, and potentially future plans and prospects. A live webcast of the call will be available on the "Investor Relations" page of the Company's website at www.jakks.com/investors. To access the call by phone, please go to this link (4Q25 Registration link), and you will be provided with dial-in details. To

    2/6/26 9:00:00 AM ET
    $JAKK
    Recreational Games/Products/Toys
    Consumer Discretionary

    Hayward Holdings Announces Fourth Quarter and Full Year 2025 Earnings Release and Conference Call Date

    Hayward Holdings, Inc. (NYSE:HAYW) ("Hayward" or the "Company"), a global designer, manufacturer, and marketer of a broad portfolio of pool and outdoor living technology, announced today it will report its fourth quarter and full year 2025 earnings results on Wednesday, February 25, 2026. Following the earnings release, the Company will hold a conference call to discuss the results at 9:00 a.m. Eastern Time that day. Interested investors and other parties can listen to a webcast of the live conference call by logging onto the Investor Relations section of the Company's website at https://investor.hayward.com/events-and-presentations/default.aspx. An earnings presentation will be posted to

    2/6/26 8:00:00 AM ET
    $HAYW
    Industrial Machinery/Components
    Industrials

    CNO Financial Group Reports Fourth Quarter and Full Year 2025 Results

    CARMEL, Ind., Feb. 5, 2026 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE:CNO) today reported its fourth quarter and full year 2025 financial results: Achieved, and in most cases exceeded, all 2025 guidance metrics.Fourth quarter 2025 net income was $93 million, or $0.95 per diluted share, and net operating income(1) was $143 million, or $1.47 per diluted share.Full year 2025 net income was $229 million, or $2.30 per diluted share, and net operating income(1) was $439 million, or $4.40 per diluted share. Return on equity (ROE) of 8.9%; Operating ROE of 11.4%, excluding signif

    2/5/26 4:15:00 PM ET
    $CNO
    Accident &Health Insurance
    Finance